Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry — Stella

Recruiting

Back to End-Stage Renal Disease trials

Trial locations(4 sites)

United States

Infirmary Heath, Mobile, Alabama

Olive View - UCLA Medical Center, Sylmar, California

Harbor-UCLA Medical Center, Torrance, California

Sentara Norfolk General Hospital, Norfolk, Virginia

Key details

Sponsor

LifeNet Health

Enrollment target

~100 participants

Started

June 2023

Primary completion

December 2027

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov